Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 33Carcinoma, Non-Small-Cell Lung 19Squamous Cell Carcinoma of Head and Neck 18Esophageal Neoplasms 17Nasopharyngeal Carcinoma 11Head and Neck Neoplasms 11Uterine Cervical Neoplasms 10Pancreatic Neoplasms 9Oropharyngeal Neoplasms 8Esophageal Squamous Cell Carcinoma 6Carcinoma, Squamous Cell 6Stomach Neoplasms 4Neoplasms 4Mouth Neoplasms 4Glioblastoma 4Colorectal Neoplasms 4Carcinoma 4Adenocarcinoma 4Urinary Bladder Neoplasms 3Pathologic Complete Response 3Hypopharyngeal Neoplasms 3Thymoma 2Resectable Esophageal Cancer 2Neoplasms by Site 2Nasopharyngeal Neoplasms 2NSCLC 2Lymphoma 2Lung Neoplasms 2Locally Advanced Malignant Neoplasm 2Laryngeal Neoplasms 2

Interventions

endostar protein 1coenzyme Q10 1apatinib 1Yoga 1Ubiquinone 1Tamoxifen 1Referral and Consultation 1Palliative Care 1Oxaliplatin 1Melatonin 1Gardening 1Exercise 1Educational Status 1Diet Therapy 1Chemoradiotherapy 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Quality of Life × Chemoradiotherapy × Clear all
NCT03588494 2018-07-17

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Affiliated Hospital of North Sichuan Medical College

Phase 2/3 Unknown
318 enrolled

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡